The Agrawal study further supports these findings by highlighting the particularly significant impact of IV iron in specific patient populations, such as those with CKD on dialysis, where it induces a faster and more substantial increase in Hb levels [28]. The gene discussed is GSTM1; the disease is chronic kidney disease.